INR 1222.2
(-1.95%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.4 Billion INR | -74.12% |
2022 | 2.36 Billion INR | 23.04% |
2021 | 1.91 Billion INR | 29.34% |
2020 | 1.48 Billion INR | 22.7% |
2019 | 1.2 Billion INR | 132.15% |
2018 | 520.87 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 144.6 Million INR | 128.8% |
2023 Q4 | 199.38 Million INR | -67.99% |
2023 Q3 | 622.85 Million INR | 7.2% |
2023 Q1 | 595.78 Million INR | 7.67% |
2023 Q2 | 581.02 Million INR | -2.48% |
2023 FY | 611.09 Million INR | -74.12% |
2022 Q1 | 600.17 Million INR | 28.09% |
2022 Q4 | 553.36 Million INR | -11.2% |
2022 Q3 | 623.14 Million INR | 6.64% |
2022 Q2 | 584.35 Million INR | -2.64% |
2022 FY | 2.36 Billion INR | 23.04% |
2021 Q1 | 425.86 Million INR | 85.97% |
2021 Q2 | 520.75 Million INR | 22.28% |
2021 Q4 | 468.57 Million INR | -6.98% |
2021 Q3 | 503.72 Million INR | -3.27% |
2021 FY | 1.91 Billion INR | 29.34% |
2020 Q3 | 438.19 Million INR | 1.74% |
2020 FY | 1.48 Billion INR | 22.7% |
2020 Q2 | 430.69 Million INR | 11.64% |
2020 Q1 | 385.78 Million INR | 109.8% |
2020 Q4 | 228.99 Million INR | -47.74% |
2019 Q3 | 337.63 Million INR | -4.78% |
2019 Q4 | 183.88 Million INR | -45.54% |
2019 FY | 1.2 Billion INR | 132.15% |
2019 Q2 | 354.59 Million INR | 3.87% |
2019 Q1 | 341.38 Million INR | 44.81% |
2018 Q3 | 285.13 Million INR | 0.0% |
2018 Q4 | 235.74 Million INR | -17.32% |
2018 FY | 520.87 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | -141.907% |
Ind-Swift Limited | 946.56 Million INR | -48.198% |
Bajaj HealthCare Limited | 985.34 Million INR | -42.365% |
Sakar Healthcare Limited | 204.07 Million INR | -587.375% |
Aurobindo Pharma Limited | 55.65 Billion INR | 97.48% |
Innova Captab Limited | 931.03 Million INR | -50.671% |
Divi's Laboratories Limited | 14.17 Billion INR | 90.1% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 43.287% |
Morepen Laboratories Limited | 1.98 Billion INR | 29.418% |
Mankind Pharma Limited | 29.27 Billion INR | 95.208% |
Sequent Scientific Limited | 2.9 Billion INR | 51.658% |
Wanbury Limited | 978.96 Million INR | -43.293% |
Laurus Labs Limited | 11.9 Billion INR | 88.222% |
Nectar Lifesciences Limited | 932.7 Million INR | -50.401% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 87.949% |
Alembic Limited | 872.45 Million INR | -60.786% |
Hikal Limited | 4.46 Billion INR | 68.574% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 91.161% |
Neuland Laboratories Limited | 2.92 Billion INR | 52.119% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 90.517% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.012% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 36.266% |
Themis Medicare Limited | 1.12 Billion INR | -24.604% |
RPG Life Sciences Limited | 1.63 Billion INR | 14.229% |
Zydus Lifesciences Limited | 125.21 Billion INR | 98.88% |
Lupin Limited | 125.09 Billion INR | 98.879% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 33.01% |
Wockhardt Limited | 8.48 Billion INR | 83.458% |
Vaishali Pharma Limited | 84.02 Million INR | -1569.411% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 54.372% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -219.87% |
Jubilant Pharmova Limited | 14.45 Billion INR | 90.295% |
FDC Limited | 3.49 Billion INR | 59.918% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.537% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -240.13% |
Eris Lifesciences Limited | 4.94 Billion INR | 71.62% |
Venus Remedies Limited | 1.91 Billion INR | 26.796% |
ZIM Laboratories Limited | 1.01 Billion INR | -38.471% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 1.158% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -2306.651% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 35.489% |
Shilpa Medicare Limited | 3.33 Billion INR | 57.927% |
Albert David Limited | 1.02 Billion INR | -36.704% |
Ajanta Pharma Limited | 30.46 Billion INR | 95.395% |
Hester Biosciences Limited | 908.84 Million INR | -54.349% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 45.077% |
Gufic Biosciences Limited | 1.18 Billion INR | -18.22% |
Windlas Biotech Limited | 1 Billion INR | -39.372% |
Procter & Gamble Health Limited | 2.99 Billion INR | 53.169% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -9769.76% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -764.702% |
Granules India Limited | 10.31 Billion INR | 86.398% |
Aarti Drugs Limited | 1.16 Billion INR | -20.155% |
Bal Pharma Limited | 555.62 Million INR | -152.47% |
Alkem Laboratories Limited | 32.83 Billion INR | 95.728% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.09% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -30.591% |
Medicamen Biotech Limited | 335.16 Million INR | -318.534% |
Unichem Laboratories Limited | 6.72 Billion INR | 79.143% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -207.909% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -20468.754% |
Valiant Laboratories Limited | 138.02 Million INR | -916.3% |
Orchid Pharma Limited | 800.77 Million INR | -75.18% |
Medico Remedies Limited | 59.67 Million INR | -2250.715% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 33.961% |
Ipca Laboratories Limited | 18.98 Billion INR | 92.612% |
Brooks Laboratories Limited | 51.18 Million INR | -2640.893% |
Syncom Formulations (India) Limited | 345.63 Million INR | -305.861% |
Piramal Enterprises Limited | 63.65 Billion INR | 97.796% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 93.452% |
NATCO Pharma Limited | 10.05 Billion INR | 86.053% |
Suven Life Sciences Limited | 109.75 Million INR | -1178.168% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2939.234% |
Strides Pharma Science Limited | 9.16 Billion INR | 84.69% |
Indoco Remedies Limited | 12.06 Billion INR | 88.369% |
Alpa Laboratories Limited | 127.38 Million INR | -1001.263% |
Lasa Supergenerics Limited | 291.17 Million INR | -381.77% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 54.408% |